|
Project
(Role: Principal
Investigator) |
Funding
Agency |
|
Corneal and scleral
permeability of drugs. Ophtha Technical Development,
[01/05-12/05].
|
Novartis AG,
Basel. |
Anti-VEGF and
antiproliferative effects of novel drugs.
[07/01/04-06/30/05]. |
Novacea, Inc. |
Biocompatibility of
SABER formulations in the eye.
[07/01/04-06/30/05].
|
Durect
Corporation. |
|
Equipment for
supercritical fluid processes.
[06/01/04-05/31/05].
|
Nebraska Banker’s Association. |
Pharmacological
approaches to treat diabetic retinopathy – minority supplement (R01
DK064172-S1).
[04/03-03/06]. |
National Institutes of Health (NEI),
Bethesda, MD. |
|
Pharmacological
approaches to treat diabetic retinopathy (R01 DK064172).
[04/03-03/06].
|
National Institutes of Health (NEI),
Bethesda, MD. |
|
Subconjunctival
route to prolong corticosteroid delivery (R03 EY013842). [08/01/03-07/31/06].
|
National Institutes of Health (NEI),
Bethesda, MD. |
Ocular drug
disposition from novel Alcon formulations.
[12/11/03-12/11/04]. |
Alcon
Laboratories, Inc.,
Fort Worth, TX. |
Ocular drug
delivery research.
[2002-present]. Unrestricted
funding. |
Santen Corporation,
Japan. |
|
Retinal delivery of
celecoxib to inhibit VEGF expression. [2001]. |
UNMC seed grant. |
|
Inhibition of VEGF
expression and angiogenesis. [04/01
- 01/02]. |
Controlled Delivery Systems, Inc,
Watertown, MA. |
|
Deslorelin transport across
bovine nasal tissue. 1[02/00
- 11/02]. |
Balance Pharmaceuticals, Inc.,
Santa Monica, CA. |
|
Assessment of bovine nasal
tissue for peptide drug transport: A feasibility study with deslorelin. [08/00
- 07/01]. |
Balance Pharmaceuticals, Inc.,
Santa Monica, CA. |
|
Mechanisms and kinetics of
degradation of deslorelin in nasal epithelial cells.
[03/00
- 02/01]. |
Balance Pharmaceuticals, Inc.,
Santa Monica, CA. |
Ocular absorption of
levobetaxolol from novel formulations - 1.
[10/98 -10/00]. |
Alcon
Laboratories, Inc.,
Fort Worth, TX. |
AAPS new investigator grant in
pharmaceutics, drug delivery and pharmaceutical technology.
[08/98 - 07/00].
|
Unrestricted research
funding. |
|
Ocular absorption of
levobetaxolol. [08/98 -
indefinite]. |
Alcon
Laboratories, Inc.,
Fort Worth, TX. |
Systemic and ocular
absorption of novel ARIs (R15 EY1177-03).
[03/97
- 02/00]. (Co-investigators: Jack DeRuiter and C. Randall Clark). |
National Institutes of Health (NEI),
Bethesda, MD. |
Production of budesonide
particles for pulmonary delivery using supercritical fluid antisolvent
precipitation technique.
[12/97
- 11/99]. (Co-investigator. Christopher B. Roberts, Department of
Chemical Engineering). |
Auburn University
Biogrant Proposal, Auburn University, Auburn, AL. |
|
Ocular absorption of drugs
from Alcon formulations. [07/97
- 06/98]. |
Alcon
Laboratories, Inc.,
Fort Worth, TX. |
A preliminary bioequivalence
study of phenylbutazone paste in horses. [04/97
- 08/97].
(Co-investigators: William R. Ravis, Ram Purohit, Sue
H. Duran). |
Med-Pharmex, Inc.,
Pomona, CA. |
|
Mechanisms of transport of
dideoxyinosine across cornea and conjunctiva. Future Life Science
Scholars Program. [06/97
- 09/97]. (Role: Mentor for James Kelly, a high school student
from Opelika). |
Sponsored by
Howard Hughes
Institute
through a core grant to Auburn University. |
|
A sustained release device
for deslorelin in treating cystic ovarian disease in cattle. Future Life
Science Scholars Program. [06/97 - 9/97]. (Role:
Mentor for Sharon Williams, a student from Tuskegee University). |
Sponsored by
Howard Hughes
Institute
through a core grant to Auburn University. |
|
Fabrication and
characterization of porous biodegradable membranes. [08/96 - 10/96].
|
DPD Inc.,
2000 Turner St., Lansing, MI. |
|
ELISA analysis of deslorelin
in rabbit plasma samples. [10/95 - 12/95]. |
Balance Pharmaceuticals, Inc., 842 Las Casas
Ave.,
Pacific Palisades, CA. |
|
Ocular Absorption of drugs
from ten formulations; [08/95
- 7/97]. |
Alcon
Laboratories, Inc.,
6201 South Freeway,
Fort Worth, TX. |
|
Influence of an
anti-glaucoma agent on rabbit corneal and conjunctival ion transport; [03/95
- 2/96]. |
Sigma Xi
Headquarters, 99 Alexander Drive- Box 13975, Research Triangle Park, NC. |
|
Deslorelin: HPLC
assay and nasal degradation (Role: Mentor for Megan Huff of Opelika). Future
Life Science Scholars Program at Auburn University; [06/95
- 8/95]. |
Sponsored by
Howard Hughes
Institute. |
|
Development and
characterization of an in vitro model for drug and ion transport across
rabbit nasal epithelial tissue. [05/95
- 04/96]. |
Auburn
University Research Grant-in-Aid. |
|
RIA and ELISA analysis of
estradiol, testosterone, and deslorelin in human serum samples. [03/95 - ]. |
Balance Pharmaceuticals, Inc., 842 Las Casas
Ave.,
Pacific Palisades, CA. |
|
RIA and ELISA analysis of
estradiol, testosterone, and deslorelin in rabbit plasma samples.
[03/95 - ]. |
Balance Pharmaceuticals, Inc., 842 Las Casas
Ave.,
Pacific Palisades, CA. |
|
RIA and ELISA analysis of
estradiol, testosterone, and deslorelin in rabbit plasma samples. [02/95
- ].
|
Balance Pharmaceuticals, Inc., 842 Las Casas
Ave.,
Pacific Palisades, CA. |
|
Project (Role:
Co-Investigator) |
Funding
Agency |
|
Pharmacokinetics of
nonsteroidal anti-inflammatory drugs in South American Camelids. [11/97-10/98].
(PI: Christine Navarre).
|
Morris
Animal Foundation,
45 Inverness Drive East, Englewood, CO 80112 |
Assessment of self-learning ability: Validation of scales and outcome
measures. [10/97].
(PI: Debbie C. Byrd). |
Auburn University Research Grant-in-Aid proposal. |
Novel GnRH agonist therapy
for cystic ovaries in cattle. [10/97 - 09/98].
(PI: James G.W. Wenzel). |
USDA for Food Animal Health and Disease Research, College of Veterinary
Medicine, Auburn University, Auburn, AL. |
|
Corneal and conjunctival
transport of novel aldose-reductase inhibitors. Future Life Science
Scholars Program.
[6/97-9/97].
[Role: Co-advised (along with Jack DeRuiter) Erika Thomas, a high school
student from Mississippi].
|
Sponsored by Howard Hughes
Institute through a core grant to Auburn University. |
A novel LHRH agonist therapy
for cystic ovaries in cattle. [10/96-9/97].
(PI: James
Wenzel). |
USDA for Food Animal Health and Disease Research, College of Veterinary
Medicine, Auburn University, Auburn, AL. |
|
Development of a nasally
administered vaccine to combat Pasteurella haemolytica in cattle. [10/96-9/97].
(PI: Sue Hudson Duran).
|
USDA for Food Animal Health and Disease Research, College of Veterinary
Medicine, Auburn University, Auburn, AL. |
Regional administration of
ceftiofur for the treatment of septic foot conditions in cattle. [10/95-9/96].
(PI: Christine B. Navarre). |
USDA for Food Animal Health and Disease Research, College of Veterinary
Medicine, Auburn University, Auburn, AL. |
Development of a nasally
administered vaccine to combat Pasteurella haemolytica in cattle. [10/95-9/96].
(PI: Sue Hudson Duran). |
USDA for Food Animal Health and Disease Research, College of Veterinary
Medicine, Auburn University, Auburn, AL. |
|
|
|